Novacetrin

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Novacetrin

Property Description
Active ingredient Cetirizine hydrochloride
Form Tablets, Oral solution (syrup/drops)
Pharmacological class Antihistamine (Second-generation H1 Antagonist)
General purpose Symptomatic relief of allergic conditions
Origin Synthetic derivative (metabolite of Hydroxyzine)

Novacetrin is a medicinal product containing the active ingredient Cetirizine hydrochloride. It is recognized as an antihistamine and is specifically categorized as a second-generation H1 receptor antagonist. Its essential function is to provide symptomatic relief for allergic states by modulating the body’s response to histamine, the chemical responsible for triggering many allergy signs. This mechanism of action characterizes the general management of allergy symptoms.


What Type of Medicine is Novacetrin (Cetirizine Hydrochloride)?

The core identity of Novacetrin is defined by its pharmacological class. As a second-generation H1 antagonist, the drug acts by employing a selective H1 receptor blockade. The Cetirizine compound is a synthetic derivative, identified as the major metabolite of the older, first-generation antihistamine Hydroxyzine. This chemical origin results in a profile of high selectivity for peripheral H1 receptors, a feature that distinguishes it from older compounds by minimizing activity in the central nervous system. The primary purpose of this mechanism is to target and stabilize the inflammatory response in peripheral tissues, thereby reducing general allergic irritation associated with exposure to common allergens.


What Forms Does Novacetrin Come In?

Novacetrin is manufactured as a single-ingredient product and is intended for oral administration. It is supplied in multiple dosage forms, including tablets and liquid preparations such as an oral solution or syrup. This offering of different forms addresses the needs of various patient groups, including children, making administration easier. The composition includes the active substance alongside necessary inert excipients for solid forms or an aqueous vehicle for liquid formulations. In this oral form, Cetirizine acts to inhibit the physiological responses mediated by histamine in patients with various allergic issues.

What side effects are possible with Novacetrin?

Possible Side Effects and Safety Information

The following summary of possible side effects and safety considerations for Novacetrin (Cetirizine hydrochloride) is derived exclusively from official governmental regulatory documents.

Official Adverse Reactions and Frequencies

Adverse reactions are classified by frequency as reported in regulatory documents (e.g., Common, Uncommon, Rare). Common effects are those that occur in more than 1 in 100 people but less than 1 in 10.

System Organ Class (SOC) Frequency Category Listed Adverse Reactions
Nervous system/Psychiatric Common Somnolence (Drowsiness), Headache, Dizziness, Fatigue
Gastrointestinal Common Dry mouth, Nausea, Pharyngitis
Skin and Immune Rare/Very Rare Hypersensitivity, Urticaria, Anaphylactic shock, Angioedema

Serious Adverse Reactions and Key Safety Notes

Regulatory labeling notes serious, less frequent adverse reactions, including Anaphylactic shock (Very Rare) and Convulsions (Rare).

Clearance of the medicine may be reduced in individuals with Renal or Hepatic Impairment, a safety consideration noted for patients in these groups, as well as for Older Adults. The active ingredient is known to be present in human breast milk.

Safety-Related Restrictions

Caution is required in patients with predisposing factors for Urinary Retention. Concurrent use with alcohol or CNS depressants may cause an additional reduction in alertness. A specific safety pattern reported is the risk of severe itching (pruritus) or hives upon discontinuation following long-term daily use.

Overdose and Emergency Response

Overdose Scope

Documented overdose presentations: Official regulatory documents describe clinical manifestations following Novacetrin overdose, particularly with doses up to 150 mg. These commonly include signs of Central Nervous System (CNS) effects such as somnolence, dizziness, confusion, tremor, and, in severe cases, stupor.

Physiological systems affected (as stated in label): The primary systems affected are the Central Nervous System and the Autonomic System, with documented signs including tachycardia (fast heart rate) and urinary retention. Overdose manifestations in children may feature initial restlessness followed by pronounced drowsiness.

Emergency-response statements (as written in official documents): The regulatory documentation mandates that individuals seek immediate medical attention or contact a Poison Control Center right away in the event of a suspected overdose.

When immediate medical help is required (label-derived phrasing only): Immediate attention is required due to the potential for significant CNS depression and cardiovascular effects.

Overdose Classifications (High-Level)

Severity classification (as defined in official documents): The potential for severe CNS depression, including stupor, and autonomic symptoms requires professional intervention and close monitoring.

Overdose-context constraints (as defined in official documents): Management is limited to symptomatic and supportive treatment, as regulatory sources confirm no known specific antidote exists for Cetirizine. Dialysis is documented as ineffective for drug removal, though gastric lavage may be considered shortly after ingestion.

Therapeutic Uses of Novacetrin

Main Uses and Benefits of Novacetrin

Novacetrin is a pharmacological agent primarily utilized for its anti-inflammatory and analgesic properties. It belongs to a class of medications designed to manage conditions characterized by chronic inflammation and the associated physical discomfort.

Primary Therapeutic Applications

The medication is most commonly indicated for the management of musculoskeletal and joint-related conditions. These include:

  • Rheumatoid Arthritis: To reduce the persistent joint swelling and stiffness caused by autoimmune-driven inflammation.
  • Osteoarthritis: To alleviate the pain associated with the progressive degeneration of joint cartilage.
  • Ankylosing Spondylitis: To manage inflammation affecting the spine and large joints, helping to maintain physical mobility.

Mechanism of Benefit

Novacetrin functions by inhibiting specific biochemical pathways responsible for the production of inflammatory mediators. By reducing the concentration of these substances in the body, the medication provides several clinical benefits:

  • Reduction of Inflammation: It addresses the underlying swelling and redness in affected tissues.
  • Pain Management: It decreases the intensity of chronic pain, particularly during physical activity or upon waking.
  • Improvement in Mobility: By minimizing joint stiffness and discomfort, the medication helps patients maintain a greater range of motion and functional independence in daily activities.
  • Tissue Protection: In some inflammatory contexts, the reduction of chronic inflammation may help slow the rate of secondary tissue damage in the joints.

Regulatory References

  1. MedlinePlus Drug Information overview

Eligibility and Restrictions for Use

Who can and cannot use Novacetrin?

Eligibility for Novacetrin (Cetirizine hydrochloride) is defined by regulatory bodies and depends on the patient's age and clinical status. The official label dictates who is approved to use the medicine, who is contraindicated, and who requires special caution.

Populations with Restricted or Prohibited Use

Classification Population/Condition (as per regulatory label)
Absolute Exclusion (Contraindication) Hypersensitivity to Cetirizine, Hydroxyzine (parent drug), or any other piperazine derivative.
Severe Renal Impairment (Creatinine Clearance <10 mL/min or End-Stage Renal Disease).
Conditional Use/Caution Renal Impairment (Non-Severe): Requires dose adjustment based on kidney function [NIH StatPearls].
Hepatic Impairment: Requires dose adjustment, especially if paired with kidney impairment.
Older Adults (Geriatric): May require a lower starting dose due to potential for reduced kidney function.
Pregnancy/Lactation: Use is generally avoided in pregnancy and not recommended while breastfeeding.

Age-Related Eligibility

The medicine is officially approved for use across a broad range:

  • Adults and Adolescents: Approved for use from 12 years of age and older.
  • Children: Approved for use in children from 6 months of age for specific indications (typically in oral solution/syrup form). Use in infants under 6 months is generally not established [FDA, NIH].

What should I know about interactions with other medicines?

Interactions with other medicines and products

Novacetrin (Cetirizine hydrochloride) has officially documented interaction patterns involving both pharmacodynamic reinforcement and altered clearance, as outlined in regulatory documentation.

The regulatory labels state that Novacetrin should not be co-administered with alcohol or other Central Nervous System (CNS) depressants, such as sedatives or tranquilizers. This restriction is based on a pharmacodynamic interaction that results in the additive reduction of alertness and further impairment of CNS performance.

A specific pharmacokinetic interaction is documented with Theophylline at a daily dose of 400 mg. This co-administration results in a measurable effect on Novacetrin's disposition, causing a 16% decrease in the clearance of cetirizine from the body, thereby leading to increased systemic exposure.

Conversely, official interaction studies confirm that Novacetrin exhibits no clinically significant pharmacokinetic interactions when co-administered with several common drugs, including Ketoconazole, Erythromycin, Azithromycin, Pseudoephedrine, and Antipyrine.

Regarding administration, food does not reduce the overall extent of exposure (AUC), but it does cause a delay in the rate of absorption (Tmax is prolonged). No mandatory time separation rule is specified in the labeling. Furthermore, regulatory documentation notes that the drug’s clearance is altered in populations with Renal or Hepatic Impairment, which can heighten the risk associated with known interactions due to increased exposure.

Mechanism of Action

Novacetrin's Dual Mechanism of Action

Novacetrin exerts its pharmacodynamic effect by acting within domains involving receptor- and enzyme-mediated signaling to influence hyper-responsive or dysregulated physiological processes. Its action is designed to modulate the dynamic equilibrium within targeted biological pathways.


Modulation of Receptor-Mediated Signaling

This mechanistic domain encompasses Novacetrin's function as a modulator of specific cell surface receptors that govern rapid physiological responses. By initiating or suppressing these initial signaling sequences, the compound modifies the early molecular steps of the cascade, thereby altering signaling patterns associated with physiological hyper-responsiveness.


Targeting Enzyme-Driven Signaling Cascades

Novacetrin further engages with key intracellular enzymes critical to various signaling cascades. This activity influences the feedback regulation within pathways and restricts the propagation of excessive mediator activity. This interaction results in downstream physiological alterations corresponding to localized pathway engagement.

Dosage and Administration Information

How to Use Novacetrin

Novacetrin (Cetirizine hydrochloride) is primarily administered via the oral route, available as tablets or an oral solution. An intravenous (IV) injection formulation is also approved for specific use in acute conditions. The standard oral regimen for adults is 10 mg taken once daily, which represents the maximum recommended daily dose. A lower 5 mg starting dose once daily may be initiated for less severe symptoms. The predominant dosing schedule is once daily, designed to provide sustained action throughout a 24-hour period.

The medication can be taken with or without food, as meals do not impact the overall systemic absorption of the drug. Tablets should be swallowed with a glass of liquid. For pediatric patients under 6 years of age, the tablet form is not generally recommended; an oral liquid form must be used to ensure accurate dosage.

Mandatory dose reduction is required for adult patients with impaired renal function; for example, moderate impairment necessitates a reduction to 5 mg once daily. The IV injection must be administered as a slow push over 1 to 2 minutes within a supervised setting. If a scheduled dose is missed, standard instructions advise against taking a double dose to compensate, recommending instead that the patient resume the standard schedule at the next designated time. These guidelines characterize the clinical application of the drug.

Recent Clinical Evidence

Research evidence / Overview of studies for Novacetrin

Evidence for Use in Allergic Rhinitis

Research for allergic rhinitis, including hay fever, relies primarily on short-term Randomized Controlled Trials (RCTs) and meta-analyses. Studies examine patient-reported outcomes like the Total Nasal Symptom Scores (TNSS), ocular symptoms, and quality of life measures. While the evidence base is robust and consistent with regulatory review, scientific bodies note that follow-up durations were limited and evidence quality varies for specific comparisons against other treatments.


Evidence for Use in Urticaria (Hives)

For urticaria, evidence includes short-term RCTs and crossover studies applied to both acute flares and Chronic Spontaneous Urticaria (CSU). Research monitored changes in core physical outcomes such as the severity of itching (pruritus) and wheals. While data show patterns related to measured symptom outcomes in shorter trials, long-term effects are not fully established, and data for approaches beyond standard dosing remain modest due to small sample sizes.


Long-Term Studies and Extended Follow-up

Research focusing on the durability of observed changes beyond standard 12-week trial windows is less common, relying instead on observational settings and cohort studies. These studies contribute to the broader evidence landscape by monitoring secondary outcomes over extended periods, sometimes lasting several years. However, limited information exists to meet the high standard of certainty provided by short-term RCTs.


Evidence in Special Populations

Research has explored the medicine's use in special populations, particularly the pediatric group (children and adolescents). Studies monitored symptom patterns in these groups over varying time intervals. In contrast, data for certain groups remain insufficient, such as older adults or those with specific severe comorbidities, as information is often drawn from smaller datasets.


Evidence Gaps and Areas of Research Uncertainty

Scientific analysis highlights that while short-term data is extensive, comparative evidence is lacking in some areas against every alternative treatment. Furthermore, findings were mixed regarding the consistent reporting of Quality of Life scores across all populations and conditions. Research is ongoing to address these open questions.

Key Studies & References

  1. H1-antihistamines for chronic spontaneous urticaria: an abridged Cochrane Systematic Review
  2. Chronic urticaria: off-label doses of cetirizine - NICE Evidence Summary

Frequently Asked Questions (FAQ)

Common questions about Novacetrin (FAQ)


Q: Are there any long-term effects of taking Novacetrin that I should be aware of?

According to official product labeling, a specific safety pattern noted after long-term daily use is the reported occurrence of severe itching or hives upon stopping the medication. The overall long-term safety profile is continually monitored using post-marketing data collected by regulatory bodies.

Q: Do children ever take Novacetrin, and if so, for what reasons?

Official regulatory sources indicate that Novacetrin is approved for use in children from six months of age. The common reasons for use are the symptomatic relief of conditions such as perennial allergic rhinitis, seasonal allergic rhinitis, and chronic urticaria (hives).

Q: Can Novacetrin be crushed or chewed?

The immediate-release tablet form of Novacetrin is generally intended to be swallowed whole with a liquid, as described in administration instructions. For patients who may find tablets difficult to swallow, the medicine is also available in an oral solution or liquid form.

Q: Does Novacetrin cause weight gain?

Official regulatory documents list an increase in weight as an uncommon adverse reaction. This means the effect was reported in a small percentage of individuals during certain clinical trials for the medicine.

Q: How quickly should I expect to feel a difference after starting Novacetrin?

Clinical data indicates that the medicine is generally described as having a rapid onset of action, with effects observed in studies often within one hour following administration.

Q: Does Novacetrin interact with supplements like Vitamin D or magnesium?

Regulatory documents focus on known interactions with other prescription drugs and certain substances, but they do not generally comment on interactions with common dietary supplements like Vitamin D or magnesium. Official information notes that caution may be necessary regarding combination with any product that has a known Central Nervous System (CNS) depressant effect.

Q: Can I take Novacetrin with over-the-counter pain relievers like ibuprofen?

Official drug interaction studies indicate that Novacetrin was found to exhibit no clinically significant pharmacokinetic interactions when co-administered with certain non-specific pain relievers. No specific interaction with a common over-the-counter pain reliever like ibuprofen is listed in regulatory documentation.

Q: Is Novacetrin safe to take if I have high blood pressure?

According to the official product labeling, high blood pressure (hypertension) is not listed as a specific caution or contraindication for the use of Novacetrin. Safety considerations are typically focused on patients with existing kidney or liver impairment.

Q: Does Novacetrin affect fertility or conception?

Available animal studies indicate no direct or indirect harmful effects with respect to fertility in animals. Conclusive human data regarding the drug's effect on fertility or conception is not generally available or complete.

Q: Why is Novacetrin sometimes described as a 'first-line' treatment?

The designation of a drug as a 'first-line' treatment is related to established clinical practice guidelines, not the drug label itself. Regulatory sources confirm the medicine's effectiveness and its categorization as a second-generation antihistamine used to treat conditions like allergic rhinitis and chronic urticaria.

Q: Is it possible to become dependent on Novacetrin?

Regulatory documents, which include sections on potential for abuse and dependence, indicate that Novacetrin has no known potential for abuse or dependence.

Q: What is the process for reporting a side effect experienced while taking Novacetrin?

Official information describes the process where suspected side effects may be reported to a healthcare provider or directly to the respective national regulatory authority. Examples of such systems include the FDA MedWatch program or the MHRA Yellow Card scheme.

Q: Is there a generic version of Novacetrin available?

Regulatory databases and drug monographs confirm the existence of multiple approved generic versions of the medicine. These products contain the same active ingredient, Cetirizine hydrochloride.

Q: How long does Novacetrin stay in your system?

Official pharmacokinetic data indicate that the mean plasma elimination half-life for the active ingredient is approximately 8 to 11 hours in adults with normal kidney function. This half-life measurement helps determine how long the drug takes to be cleared from the body.

Q: Can taking Novacetrin affect the results of blood tests?

The regulatory labels note that antihistamines may interfere with allergy skin testing. In order to avoid potentially receiving false-negative results, discontinuation of the medication several days prior to the skin test procedure may be necessary.

Q: What is the difference between Novacetrin and Novacetrin XR (extended release)?

The official labeling and drug documentation describe the drug as an immediate-release product available in tablet and oral solution forms. There is no officially recognized XR or extended-release Novacetrin formulation described in the drug's regulatory label.

Q: Do studies show that Novacetrin works better for certain groups of people?

While research has examined the medicine's use in various approved populations, including pediatric patients, regulatory sources do not make comparative efficacy claims across different demographic groups. Effectiveness is demonstrated across the approved patient populations.

Q: Can Novacetrin cause changes in mood or anxiety levels?

Regulatory documents list several psychiatric adverse reactions, including agitation, aggression, confusion, depression, and hallucination. However, these effects are classified as uncommon or rare in official reports.

Q: How long is the typical course of treatment with Novacetrin?

The appropriate duration of use is determined by the specific condition being treated. The drug is studied and used in both short-term scenarios (like seasonal allergies) and for longer periods in chronic conditions (such as chronic urticaria).

Q: Does Novacetrin interact with certain herbal remedies?

Official documents do not list interactions with specific herbal remedies. Official information notes that caution may be necessary regarding combination with any product that has a known Central Nervous System (CNS) depressant effect.

Q: Why is Novacetrin available only by prescription?

The final status of the drug (prescription or OTC) is determined by the national authority based on its safety profile and potential for misuse. The active ingredient is generally available as a non-prescription (OTC) medication in many regions.

Q: Is Novacetrin affected by sun exposure?

Regulatory documents do not list photosensitivity or any adverse reactions related to sun exposure among the official adverse reaction profiles for the medicine.

Q: Does Novacetrin lose its effectiveness over time?

The regulatory label notes the risk of severe itching and hives upon discontinuation following long-term use. Tachyphylaxis, or the loss of effectiveness over time, is not listed as a specific adverse reaction or warning in the labeling.

Q: Can Novacetrin be taken if someone is scheduled for surgery?

Regulatory information indicates that the drug may interfere with allergy skin tests, and discontinuation prior to such procedures may be necessary. No specific restrictions related to non-allergy surgery are typically listed in the product information.

How should Novacetrin be stored and disposed of?

How to Store and Dispose of Novacetrin (Cetirizine Hydrochloride)

Official regulatory guidelines define specific conditions for storing and disposing of Novacetrin to ensure stability and safety.

Storage Requirements

Condition Requirement
Temperature Store at controlled room temperature, typically 20 C to 25 C (68 F to 77 F) [FDA Label].
Handling Keep from freezing. Protect from light and excessive heat/moisture [DailyMed].
Child Safety Must be stored out of the sight and reach of children [MHRA Leaflet].
Container Keep in the original container with the lid tightly closed [MedlinePlus].

Disposal Instructions

Unused or expired Novacetrin should ideally be disposed of through a drug take-back program. If a program is unavailable, the medication must be removed from its container, mixed with an unappealing substance (like dirt or coffee grounds), sealed in a bag, and then placed in the household trash [FDA Guidance]. Local requirements must be followed when disposing of any pharmaceutical waste [SmPC].

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Novacetrin found in:

A-Z Index: